<DOC>
	<DOCNO>NCT02956330</DOCNO>
	<brief_summary>The purpose non interventional retrospective study continue collect data patient follow completion Protocol CLS 1003-201 : `` Safety Efficacy Suprachoroidal CLS-TA Intravitreal Aflibercept Subjects Macular Edema Following Retinal Vein Occlusion '' ( ie , parent study ) .</brief_summary>
	<brief_title>Retrospective Study Safety Efficacy Patients With RVO Subjects Who Completed Parent Study CLS1003-201</brief_title>
	<detailed_description>This non-interventional , retrospective study 6 month subject complete parent study CLS1003-201 . This study design collect data patient follow parent study exit visit , either time next treatment RVO least 6 month follow parent study exit visit , whichever occur first . During non-interventional retrospective study , follow data collect online questionnaire ( require , paper ) provide Clearside : - Next RVO therapy administer ( applicable ) , include reason treatment - Continued documentation current change medical ocular condition follow parent study - Concomitant drug therapy change - Visual acuity , include detail method use assessment - Central retinal thickness , include detail equipment use determination - Intraocular pressure , include detail equipment use determination Subjects select base parent study primary investigator 's access medical record access , follow exit CLS1003-201 . Data also collect total number patient include non interventional study well reason patient exclude . Data summarize randomization treatment assignment parent study .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>Completed enrollment receive additional aflibercept therapy Parent study , CLS1003201</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>RVO</keyword>
	<keyword>ME</keyword>
	<keyword>Central Subfield Thickness</keyword>
	<keyword>OCT</keyword>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Cystoid Macular Edema</keyword>
	<keyword>Subretinal Fluid</keyword>
	<keyword>Eylea</keyword>
	<keyword>Aflibercept</keyword>
	<keyword>Anti-VEGF</keyword>
</DOC>